title: How Should We Treat Depression in Patients with Cardiovascular Disease?
abstract: Among patients with cardiovascular disease (CVD), depression is highly prevalent and is associated with worse cardiovascular prognosis and lower quality of life. Treatments for depression in CVD patients produce modest, but clinically significant reductions in depressive symptoms and show promise for improving cardiovascular prognosis. While tricyclics should generally be avoided, antidepressants from multiple other classes appear to be safe in cardiac patients. A strategy of engaging patients in choosing medications or psychotherapy and then intensifying treatment to therapeutic goal appears to be more effective at reducing depression than single mode interventions. Recommendations for screening all CVD patients for depression may be premature given increased costs associated with screening and gaps in knowledge about the risk-benefit ratio of depression treatment in mild and moderately depressed patients.
authors.affiliation: Department of Medicine, Columbia University Medical Center, New York, New York.
authors.forename: Ian M
authors.initials: IM
authors.lastname: Kronish
authors.forename: David J
authors.initials: DJ
authors.lastname: Krupka
authors.forename: Karina W
authors.initials: KW
authors.lastname: Davidson
references.citation: JAMA. 2009 Oct 21;302(15):1651-7
references.pmid: 19843899
references.citation: Biol Psychiatry. 2008 Oct 15;64(8):660-6
references.pmid: 18602090
references.citation: JAMA. 2003 Jun 18;289(23):3106-16
references.pmid: 12813116
references.citation: Psychosom Med. 2004 Nov-Dec;66(6):814-22
references.pmid: 15564344
references.citation: JAMA. 2002 Aug 14;288(6):701-9
references.pmid: 12169073
references.citation: JAMA. 1993 May 26;269(20):2673-5
references.pmid: 8487453
references.citation: J Gen Intern Med. 2006 Nov;21(11):1178-83
references.pmid: 16899061
references.citation: Cardiol Rev. 2006 Jul-Aug;14(4):164-9
references.pmid: 16788327
references.citation: Circulation. 2008 Oct 21;118(17):1768-75
references.pmid: 18824640
references.citation: Clin Trials. 2007;4(5):548-59
references.pmid: 17942470
references.citation: J Am Coll Cardiol. 2009 Sep 1;54(10):886-90
references.pmid: 19712796
references.citation: JAMA. 2009 Nov 18;302(19):2095-103
references.pmid: 19918088
references.citation: JAMA. 2007 Jan 24;297(4):367-79
references.pmid: 17244833
references.citation: Psychosom Med. 2004 Nov-Dec;66(6):802-13
references.pmid: 15564343
references.citation: N Engl J Med. 2008 Jan 17;358(3):252-60
references.pmid: 18199864
references.citation: Arch Gen Psychiatry. 2010 May;67(5):480-8
references.pmid: 20439829
references.citation: J Am Coll Cardiol. 2006 Dec 5;48(11):2209-14
references.pmid: 17161247
references.citation: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD008012
references.pmid: 21901717
references.citation: Arch Intern Med. 2005 Nov 28;165(21):2508-13
references.pmid: 16314548
references.citation: JAMA. 2008 Nov 12;300(18):2161-71
references.pmid: 19001627
references.citation: Am J Cardiol. 2011 Apr 1;107(7):972-9
references.pmid: 21256471
references.citation: Arch Gen Psychiatry. 2009 Apr;66(4):387-96
references.pmid: 19349308
references.citation: Psychosom Med. 2007 Sep-Oct;69(7):606-13
references.pmid: 17846258
references.citation: Arch Intern Med. 2010 Apr 12;170(7):600-8
references.pmid: 20386003
references.citation: N Engl J Med. 2010 Dec 30;363(27):2611-20
references.pmid: 21190455